Novartis Pelacarsen Miss Hits Amgen as Lp(a) Class Faces New Test
The 8,323-patient Lp(a)HORIZON trial failed its cardiovascular primary; Amgen shares fell about 10% on class read-through. Business • Biotech •...
The 8,323-patient Lp(a)HORIZON trial failed its cardiovascular primary; Amgen shares fell about 10% on class read-through. Business • Biotech •...
National pump diesel set a new daily high while California averaged about $7.83; this is a product story, not a...
CBSA 15/25/50% levies cover CA$27.6 billion of U.S. goods; White House signed three annex-limited exclusion proclamations for alcohol, dairy products,...
August payrolls rose 162,000 as markets price a roughly 58-60% chance of a 25 bp hike at the Sep. 15-16...
Customs data show imports up 28.2% and a $29.18 billion surplus with the U.S., with reciprocal tariff talks still exploratory....
Industrials underperformed on the first cash close after Labor Day while energy stocks rose and IXC and XOP posted new...
Surtaxes of 15% to 50% hit about CA$27.6 billion of U.S. goods; Washington's same-day moves were scope tweaks and procurement...
Multi-generation silicon and optical collaboration disclosed with a purchase-vested warrant; $60 billion is a vesting ceiling, not a firm order...
Cash deal with Warburg Pincus and Berkshire Partners aims to lock in scarce aero castings; close targeted for the second...